AZT (azidothymidine) is the primary drug currently being used to treat AIDS patients. AZT had been researched in the 1950's as a possible cancer treatment, but was abandoned in 1964 for being too toxic. The drug, technically a "DNA chain terminator", is absorbed into cells and interferes with the replication of the basic building blocks of life.
Although the immediate results of AZT treatment in AIDS patients may appear positive, over time AZT begins to produce the exact same symptoms as AIDS itself. This is particularly dangerous when we consider that AZT treatment is now being given to asymptomatic HIV-antibody positive people. When they later develop illnesses characteristic of AIDS is it fair to consider their condition AIDS? In all probability, these patients are reacting to the extremely toxic drug they have been prescribed.
For more extensive information on AZT and more, please see the links section of our site.
NEW! AZT Research Citations
AZT CANCER RISK
A multicenter study found that AZT (Zidovudine) had been incorporated into
the DNA of white blood cells from HIV-positive patients (both adults and
infants) who were treated with the drug, and the researchers suggested that
mutations and cancer may be the long term consequences.
http://hiv.medscape.com/4367.rhtml
AZT TREATMENT OF MOTHERS HARMS INFANTS
Italian researchers found that when HIV-positive women were given AZT
treatment during pregnancy, "HIV infection" progressed more rapidly in their
infants than in the infants of HIV positive women not given the drug.
http://hiv.medscape.com/4241.rhtml
|